Companies / United Therapeutics Corp

United Therapeutics Corp

Nasdaq: UTHRCIK 1082554SILVER SPRING, MD

Financials · FY2025

Revenue$3.18B
Net income$1.33B
Total debt—
Cash$1.80B
Diluted EPS$27.86
Shares outstanding42.9M

Ownership

42.9M shares outstanding · as of Jul 29, 2026
0.97%Insiders
Ownership
Insiders0.97%417,845
10%+ / strategic5.31%2,278,348
Institutions97.17%41,674,848
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 12

View all →
Insider% of sharesShares
Rothblatt Martine aCEOChairperson & CEO · Director
0.70%298,523
Mahon Paul aEVP & GENERAL COUNSEL
0.11%45,172
Benkowitz MichaelPRESIDENT AND COO
0.04%19,046
Edgemond JamesCFO AND TREASURER
0.04%18,876
Kurzweil RayDirector
0.03%12,670
Thompson Tommy GDirector
0.02%8,480
Mesa NildaDirector
0.01%5,028
Olian Judy D.Director
<0.01%4,245
Causey ChristopherDirector
<0.01%4,190
Patusky ChristopherDirector
<0.01%1,490

Institutional holders 842

View all →
HolderValue% of shares
BlackRock, Inc.$2.87B12.34%
Vanguard Group Inc$2.03B9.74%
Avoro Capital Advisors LLC$1.27B6.08%
Wellington Management Group LLP$1.19B5.69%
Renaissance Technologies LLC$1.06B4.17%
State Street Corporation$1.03B4.43%
Geode Capital Management, LLC$729.92M2.87%
Janus Henderson Group PLC$514.02M2.02%
AQR Capital Management, LLC$486.42M1.93%
Assetmark, Inc$365.31M1.44%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 15, 2026Rothblatt Martine a
CEO
OtherCommon Stock$8.34M-16K
-27.75%
40,513
0.09% of shares
low
Mar 15, 2026Rothblatt Martine a
CEO
OtherCommon Stock$7.31M-14K
-19.56%
56,072
0.13% of shares
low
Feb 17, 2026Benkowitz Michael
Executive
SellCommon Stock$7.03M-15K
-100.00%
0
0.00% of shares
medium
Jan 12, 2026Benkowitz Michael
Executive
SellCommon Stock$7.01M-15K
-100.00%
0
0.00% of shares
medium
Feb 9, 2026Benkowitz Michael
Executive
SellCommon Stock$6.94M-15K
-100.00%
0
0.00% of shares
medium
Jan 26, 2026Benkowitz Michael
Executive
SellCommon Stock$6.90M-15K
-100.00%
0
0.00% of shares
medium
Feb 2, 2026Benkowitz Michael
Executive
SellCommon Stock$6.89M-15K
-100.00%
0
0.00% of shares
medium
Feb 23, 2026Benkowitz Michael
Executive
SellCommon Stock$4.43M-9K
-100.00%
0
0.00% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A—0—
Wellington Management Group LLPPassive13G———
Vanguard Capital ManagementPassive13G—2,278,348—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
UTHR——91307C102—